ArticleFrontiers in immunology2026

Baseline glucose-to-lymphocyte ratio predicts nivolumab outcomes in advanced non-small cell lung cancer: a multicenter retrospective study.

Mustafa Ersoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.